XBiotech XBIT
NASDAQ XBIT
$2.20 +0.01 (+0.46%)
At close: Oct 1, 2026 · 4:00 PM EDT

XBiotech (XBIT) Change in Interest Receivables (2022 - 2025)

Updated

XBiotech (XBIT) reported Change in Interest Receivables of -$90,000 for Q4 2025, compared with -$30,000 a year earlier.

Analysis

XBiotech (XBIT) Change in Interest Receivables (2022 - 2025) Analysis & Trends

For FY2025, XBiotech posted Change in Interest Receivables of -$340,000.

  • By year, Change in Interest Receivables came in at -$160,000 in FY2024, -$356,000 in FY2023 and $1.22 million in FY2022.
  • Five-year quarterly Change in Interest Receivables spans a low of -$2.34 million in Q3 2023 and a high of $1.22 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Interest Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 XBiotech 66.77 Mn 66.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -90,000.00
Sep 30, 2025 -30,000.00
Mar 31, 2025 -220,000.00
Dec 31, 2024 -30,000.00
Sep 30, 2024 -140,000.00
Mar 31, 2024 10,000.00
Dec 31, 2023 -21,000.00
Sep 30, 2023 -2.34 Mn
Jun 30, 2023 846,000.00
Mar 31, 2023 1.16 Mn
Dec 31, 2022 1.22 Mn
API Access

XBiotech Change in Interest Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-interest-receivables&ticker=XBIT&period=max&api_key=YOUR_API_KEY